Clinical trials of medicinal products with the participation of a minor or juvenile may be conducted only if the relevant medicinal product is intended for the treatment of childhood diseases or if the purpose of clinical trials is to optimise the dosage or administration schedule of the medicinal product for minors or juveniles, respectively.